During the past two decades, the clinical use of biopharmaceutical products has markedly
increased because of their obvious advantages over conventional small-molecule drug …

Mesoporous silica nanoparticles have attracted much attention in recent years as drug and
gene delivery systems for biomedical applications. Among their most beneficial features for …

The regenerative capacity of an adult cardiac tissue is insufficient to repair the massive loss
of heart tissue, particularly cardiomyocytes (CMs), following ischemia or other catastrophic …

The development of cardiac patches by the combination of bioactive nano-and bio-materials
with mesenchymal stem cells signifies an auspicious approach for the treatment of cardiac …

Cardiovascular disease (CVD) is currently one of the primary causes of mortality and
morbidity worldwide. Nanoparticles (NPs) are playing increasingly important roles in …

Myocardial infarction (MI) is one of the leading causes of mortality worldwide. It is caused by
an acute imbalance between oxygen supply and demand in the myocardium, usually …

Therapy based on stem cells utilizes these cells in neurodegeneration, brain/spinal cord
injury, and much recently in repairing of severe heart diseases. Owning to their stemness …

Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Page 109 REVIEW
published: 24 June 2020 doi: 10.3389/fbioe. 2020.00687 Nanoparticle-Mediated Drug Delivery …

Amaç: Nanopartiküller, sahip oldukları üstün fiziksel özellikleri nedeniyle biyoteknoloji,
farmakoloji, tıp, sensörler, bilişim ve iletişim, elektronik, savunma, tekstil, makine ve inşaat …